King of Prussia, PA. Greenphire, the industry-leading provider of payment technologies for the clinical trials industry, today announced a relationship with Oracle Health Sciences. Oracle and Greenphire are integrating their respective product suites to enable their clients to streamline and automate processes from trial planning and budgeting, all the way through data capture to executing payments to clinical sites and patients, while providing real-time, strategically valuable reporting and analytics.
The first initiative will be the integration of Greenphire’s global payment platform, eClinicalGPS, with Oracle’s electronic data capture (EDC) solutions, Oracle Health Sciences InForm and Oracle Remote Data Capture (RDC). This integration will help ensure that clients have quick product implementations without relying on internal development and staffing. Data sharing between EDC and payment technologies will enable a virtually seamless transition between the collection and capture of clinical data and the accurate execution of payments. Greenphire and Oracle are currently working with three joint clients including two top 10 global biopharmaceutical clients and a fast growing biotechnology client.
“Clinical trial sponsors and their CRO partners are focused on improving productivity and efficiency across their clinical programs – including study set up, recruitment, data collection and analysis, as well as the administration of and payments to research sites and participants. Integrations between the Oracle and Greenphire product suites can help biopharmaceutical companies and CROs achieve new levels of efficiency and deliver powerful analytics that support continuous improvement. This will enable companies to re-direct freed up resources to discovery and development initiatives,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.
“Greenphire is committed to continually finding ways to increase efficiencies in clinical research processes and to drive value and cost savings for our clients,” said Greenphire Founder & CEO Sam Whitaker, “Our relationship with Oracle is a tremendous opportunity to find innovative ways to streamline existing processes and to ultimately simplify financial planning and management of clinical trials, by working with a company that offers world-class e-clinical solutions.”
Greenphire is a leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web‐based payment technologies to help our clients improve operational efficiency, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. Greenphire’s eClinicalGPS turns payments to investigators, a historically manual and tactical task‐driven administrative process, into an automated process that provides strategic value to Greenphire's clients. It facilitates accurate payment calculation, manages complex payment approval processes, and automates payment execution in local currencies from sponsors and CROs to all investigators, sites and vendors involved in a clinical trial on a global basis. Learn more at www.greenphire.com.
About Oracle Health Sciences
At Oracle, we believe that a more predictive, preventive, personalized and participatory system will help improve human health. We can help accelerate this journey to personalized medicine through technology, data and insights. Oracle's solutions support industry initiatives to improve care quality and outcomes, reduce costs, and speed time to market for new treatments, therapies and devices. Oracle Health Sciences delivers comprehensive business applications, plus database, middleware, and hardware solutions for life sciences and healthcare companies and institutions worldwide. For more information, visit http://www.oracle.com/us/industries/health-sciences/index.html
Oracle and Java are registered trademarks of Oracle and/or its affiliates.